| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Surgery Partners, Inc. Common Stock
$15.36
-0.19 (-1.26%)
Market Cap
2.01 B
EPS
-0.58
P/E Ratio
-
Value Trade
19.16 M
SEC Financials
Q1 2026Dilution Risk
Revenue
810.90 M
Operating CF
11.70 M
Total Assets
8.04 B
Total Liabilities
8.04 B
Equity
1.69 B
-1.37 %
Week
-0.88 %
1 Month
14.95 %
3 Month
17.51 %
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
182.30 M
Monthly Burn
-
Runway
-
Burn Trend
StableSEC Filing
May 5, 2026
Overview
Volume
378.87 K
52 Week Range
11.41 - 24.10
% held by Insiders
40.41 %
% held by Institutions
84.18 %
Enterprise Value
1.87 B
Total Shares
130.81 M
Short %
18.96 %
Float Shares
78.09 M
Company Description
locked
Upcoming Catalyst
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in SGRY
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
SGRY Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-09-18 | 0.00 | 0 | - | - | - | - | - | - | ||||
| 2026-09-18 | 0.00 | 0 | - | - | - | - | - | - | ||||
| 2026-09-18 | 0.00 | 0 | - | - | - | - | - | - | ||||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-SGRY
Aug 10, 2026▼ -1.3%today
Surgery Partners, Inc. Announces Second Quarter 2026 Results Reaffirms Full Year 2026 Guidance
Surgery Partners, Inc. reported a 2.7% revenue increase for Q2 2026, with same-facility revenues up by 5.0%. Despite a net loss of $15.0 million, the company reaffirmed its full-year revenue guidance of $3.35 billion to $3.45 billion. The CEO highlighted strategic initiatives and the importance of the pending Idaho Falls transaction for financial optimization.
Read more →-SGRY
Jul 24, 2026Surgery Partners Announces Entry Into Agreement to Sell Ownership Interests in Idaho Falls Facilities to Intermountain Health; Reaffirms Guidance, Excluding Impact of Transaction
Surgery Partners, Inc. announced an agreement to sell its ownership interests in Idaho Falls facilities to Intermountain Health for approximately $795 million. The transaction, valued at $1.15 billion, is expected to enhance Surgery Partners' financial position and support its strategic focus on the ambulatory surgery center sector. However, completion is contingent on obtaining necessary approvals.
Read more →-SGRY
Jul 15, 2026Premier Plastic Surgery Partners Introduces Revolutionary Junera™ Regenerative Skin Treatment Across Partner Practices
Premier Plastic Surgery Partners has launched the Junera regenerative skin treatment across its network. Developed by Onyxa Medical, this innovative treatment utilizes advanced biostimulation technology to enhance skin quality and promote collagen remodeling. The initiative follows extensive evaluations by key opinion leaders within the organization, aiming to meet the growing demand for effective, long-lasting aesthetic solutions.
Read more →-SGRY
Jul 14, 2026PREMIER PLASTIC SURGERY PARTNERS APPOINTS HUGH O'NEILL TO LEAD CORPORATE DEVELOPMENT
Premier Plastic Surgery Partners has appointed Hugh O'Neill as Director of Physician Partnerships to drive corporate development and growth. O'Neill will collaborate with leadership to integrate plastic surgery practices while ensuring clinical autonomy. The organization aims to expand its national presence by partnering with top-tier practices committed to patient outcomes and innovation.
Read more →-SGRY
May 5, 2026Surgery Partners, Inc. Announces First Quarter 2026 Results Reaffirms Full Year 2026 Guidance
Surgery Partners, Inc. reported a 4.5% increase in revenue for Q1 2026, totaling $810.9 million, despite a net loss of $35.9 million. The company reaffirmed its full-year revenue guidance of $3.35 billion to $3.45 billion and an Adjusted EBITDA of at least $530 million. CEO Eric Evans highlighted confidence in the company's growth strategy and operational management.
Read more →-SGRY
Apr 17, 2026Surgery Partners, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Details
Surgery Partners, Inc. has announced that it will release its first quarter 2026 earnings results on May 5, 2026, before the market opens. A conference call will follow at 8:30 a.m. Eastern Time, allowing investors to engage directly with the company's leadership. The call will be accessible via phone and webcast, with a replay available for a limited time.
Read more →-SGRY
Mar 3, 2026▼ -12.3%on this news
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2025 Results; Sets 2026 Guidance; Announces Share Repurchase Program
Surgery Partners, Inc. reported a 6.2% increase in full-year revenues for 2025, totaling $3.3 billion. Despite facing unexpected challenges in the fourth quarter, the company remains optimistic about future growth, particularly in higher-acuity procedures. They have also initiated a $200 million share repurchase program to enhance shareholder value. The company is focused on operational improvements and strategic initiatives for 2026.
Read more →-SGRY
Dec 11, 2025Surgery Partners, Inc. Announces Add-On Senior Notes Offering
Surgery Partners, Inc. announced an offering of $425 million in senior unsecured notes due 2032. The proceeds will be used for general corporate purposes, including repaying debt. This move reflects the company's ongoing growth strategy in the surgical services sector, despite potential market risks.
Read more →-SGRY
Dec 11, 2025SURGERY PARTNERS, INC. ANNOUNCES PRICING OF ADD-ON
Surgery Partners, Inc. has announced the pricing of $425 million in senior unsecured notes due 2032 through its subsidiary, Surgery Center Holdings, Inc. The offering, which is set to close on December 16, 2025, aims to further the company's general corporate purposes, including debt repayment. The notes will be offered under specific regulations to qualified institutional buyers and non-U.S. persons. This follows the original issuance of $800 million of similar notes in April 2024.
Read more →-SGRY
Dec 11, 2025SURGERY PARTNERS, INC. ANNOUNCES ADD-ON
Surgery Partners, Inc. announced its intention to offer an additional $425 million in 7.250% senior unsecured notes due 2032, through its subsidiary Surgery Center Holdings, Inc. The proceeds from this offering will be utilized for general corporate purposes, including repaying existing borrowings. As a leading healthcare services company, Surgery Partners aims to enhance its financial stability and support its ongoing operational expansion. However, the success of this offering is contingent on market conditions and carries some inherent risks.
Read more →-SGRY
Nov 10, 2025▼ -25.4%on this news
SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2025
Surgery Partners, Inc. reported its Q3 2025 financial results showing a revenue increase of 6.6% year-over-year, reaching $821.5 million. Despite the growth in revenue and Adjusted EBITDA by 6.1%, the company also recorded a net loss of $22.7 million. The leadership indicated that softer-than-expected volume trends and changes in the payor mix influenced their decision to revise guidance for the year. Overall, the company remains committed to operational excellence amidst ongoing market challenges.
Read more →-SGRY
Aug 5, 2025SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2025 RESULTS REAFFIRMS FULL YEAR 2025
Surgery Partners, Inc. reported an 8.4% increase in revenue for the second quarter of 2025, reaching $826.2 million, alongside a 9.0% rise in Adjusted EBITDA to $129.0 million. The Company reaffirmed its full-year guidance for revenue and Adjusted EBITDA, projecting them at $3.30 billion to $3.45 billion and $555 million to $565 million, respectively. Although the firm faced a net loss of $2.5 million this quarter, it continues to show operational growth and confidence in its strategic direction.
Read more →-SGRY
Jun 17, 2025▼ -12.3%on this news
SURGERY PARTNERS, INC. and Bain Capital Conclude Discussions -- Board reaffirms its confidence in the Company's long-term growth prospects Company reiterates full-year 2025 financial guidance Company expects to host an I
Surgery Partners, Inc. has concluded discussions with Bain Capital regarding a proposal for acquisition, with the Board reaffirming its confidence in the company's long-term growth as an independent entity. The Independent Committee, with advisory assistance, believes that sustaining the company as a publicly traded organization will generate greater value than pursuing the acquisition. The company has reiterated its revenue and EBITDA guidance for 2025, projecting strong performance across its operations driven by favorable market trends. Additionally, Surgery Partners plans an Investor Day in 2025 to outline its growth strategy and operational efficiencies.
Read more →-SGRY
May 12, 2025SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2025 RESULTS REAFFIRMS FULL YEAR 2025
Surgery Partners, Inc. announced its financial results for the first quarter of 2025, indicating an 8.2% increase in revenue year-over-year. The company also reaffirmed its guidance for the full year 2025, with anticipated revenues and Adjusted EBITDA in the range of $3.30 billion to $3.45 billion and $555 million to $565 million, respectively. However, the company reported a net loss of $37.7 million for the quarter, and cash flows from operating activities decreased significantly compared to the previous year. Overall, the company maintains a positive outlook despite the loss, citing operational efficiencies and growth trends in the surgical sector.
Read more →-SGRY
Mar 3, 2025SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 RESULTS SETS 2025
Surgery Partners, Inc. announced its financial results for the fourth quarter and full year of 2024, showing significant revenue growth but also a substantial net loss. The company reported a 17.5% increase in revenue for Q4 and a 13.5% increase for the full year, alongside a rise in Adjusted EBITDA. Looking ahead, Surgery Partners projects revenue for 2025 to be between $3.30 billion to $3.45 billion, with expectations for continued growth despite challenges related to tax liabilities and net losses.
Read more →-SGRY
Jan 28, 2025▲ +21.2%on this news
Surgery Partners, Inc. Confirms Receipt of Non-Binding Acquisition Proposal from Bain Capital
Surgery Partners, Inc. announced the receipt of a non-binding acquisition proposal from Bain Capital to acquire outstanding shares at $25.75 each. This proposal requires the approval of non-affiliated shareholders and a Special Committee of independent directors. No decisions on the proposal have been made, and there is no guarantee of a definitive offer or agreement. Surgery Partners remains cautious, advising shareholders about the uncertainty surrounding the proposal.
Read more →-SGRY
Jan 13, 2025SURGERY PARTNERS, INC. NAMES LAURA L. FORESE
Surgery Partners, Inc. has appointed Dr. Laura L. Forese as an independent director on its Board of Directors, effective January 10, 2025. With a robust background in healthcare administration, Dr. Forese has served as the executive vice president and COO at New York-Presbyterian. Her experience aims to strengthen the Board as they focus on operational efficiency and growth in surgical services. The board now expands to eleven members with her addition.
Read more →-SGRY
Nov 12, 2024▼ -5.9%on this news· ran to -27% by day 3
SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2024
Surgery Partners, Inc. reported strong financial results for the third quarter of 2024, with revenues increasing by 14.3% compared to the previous year, reaching $770.4 million. The company also experienced a significant rise in Adjusted EBITDA, which grew by 21.9% to $128.6 million. Despite these positive metrics, Surgery Partners reported a net loss of $31.7 million for the quarter. The company reaffirmed its revenue and Adjusted EBITDA guidance for the full year 2024, signaling confidence in their growth trajectory.
Read more →-SGRY
Aug 6, 2024Year-to-date, operating cash flows were $123.5 million compared to $126.6 million in the prior year period. Free Cash Flow, defined as operating cash flows less distributions to non-controlling interests and less mainten
Surgery Partners, Inc. reported strong financial results for the second quarter of 2024, with revenues increasing 14.2% year-over-year to $762.1 million and Adjusted EBITDA growing 18.1%. The company raised its full-year guidance, projecting revenues exceeding $3.075 billion and Adjusted EBITDA over $508 million. Despite the positive results, the company recorded a net loss of $15.5 million and a slight decrease in year-to-date operating cash flows compared to the previous year. The executive team remains confident in the company's growth strategy fueled by acquisitions and operational execution.
Read more →-SGRY
May 7, 2024▲ +8.5%on this news
SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2024 RESULTS RAISES FULL YEAR 2024
Surgery Partners, Inc. reported its financial results for the first quarter of 2024, highlighting a revenue increase of 7.7% year-over-year to $717.4 million, alongside a sizable growth in same-facility revenues. Despite a net loss of $12.4 million, the company raised its full-year revenue guidance to at least $3.05 billion. The growth was attributed to successful acquisitions and strategic operational execution. However, cash flows from operating activities saw a decline compared to the previous year, raising potential concerns regarding liquidity.
Read more →-SGRY
Mar 26, 2024SURGERY PARTNERS
Surgery Partners, Inc. has announced the pricing of $800 million in 7.250% senior unsecured notes due in 2032. The proceeds will be used to redeem outstanding notes and fund future corporate activities, indicating a growth-oriented strategy. The offering is expected to close on April 10, 2024, pending customary conditions. The company, based in Brentwood, Tennessee, focuses on high-quality outpatient surgical services and has seen significant growth across the country.
Read more →-SGRY
Feb 26, 2024▼ -8.6%on this news
SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 RESULTS SETS 2024
Surgery Partners, Inc. reported its fourth quarter and full year 2023 results, showcasing an 8.0% increase in annual revenue to $2.74 billion. Adjusted EBITDA saw a notable 15.2% rise to $438.1 million for 2023. The company is optimistic about 2024, projecting revenues greater than $3 billion and adjusted EBITDA exceeding $495 million. Despite reporting a net loss attributable to common stockholders, the company highlighted strong same-facility revenue growth and strategic initiatives aimed at future growth.
Read more →-SGRY
Dec 18, 2023Information Relating to Part II. Item 14. - Other Expenses of Issuance and Distribution The expenses in connection with the offer and sale of common stock of Surgery Partners, Inc., registered pursuant to the Registratio
Surgery Partners, Inc. has disclosed details regarding the expenses associated with the offer and sale of its common stock, as part of its Registration Statement filed with the SEC. The estimated total expenses are approximately $739,485.95, comprising various fees including legal, accounting, and printing expenses. The announcement specifically outlines costs related to the SEC registration fee, among others. This information is crucial for potential investors to understand the financial implications of the stock issuance.
Read more →-SGRY
Nov 7, 2023▲ +14%on this news
SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2023
Surgery Partners, Inc. announced its third quarter 2023 financial results, showing revenues of $674.1 million, an increase of 8.6% year-over-year. Despite a net loss of $4.9 million for the quarter, the company experienced growth in Adjusted EBITDA, which rose by 9.7% to $105.5 million. Notably, the full-year Adjusted EBITDA guidance has been raised, indicating confidence in ongoing performance. The company also reported significant cash flow generation and positive growth in surgical case volumes across its facilities.
Read more →-SGRY
Aug 1, 2023SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2023
Surgery Partners, Inc. reported strong financial results for Q2 2023, with revenues growing by 8.5% to $667.6 million, despite a headwind from a cyber event. The company raised its Adjusted EBITDA guidance for the year to over $435 million, reflecting confidence in ongoing growth. Key metrics such as same-facility revenues and surgical case volumes also showed promising increases. Leadership highlighted the successful capital deployment and the expansion of facilities as critical to their growth strategy.
Read more →-SGRY
May 1, 2023SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2023
Surgery Partners, Inc. reported its financial results for the first quarter of 2023, showing a revenue increase of 11.7% to $666.2 million. Although the company recorded a net loss of $24.9 million, adjusted EBITDA rose by 17% to $90.1 million. The company's leadership expressed optimism about future growth, raising the full-year Adjusted EBITDA forecast to over $430 million and announcing new strategic partnerships with Intermountain Health and OhioHealth. However, cash flows from operating activities slightly declined compared to the previous year.
Read more →-SGRY
Mar 1, 2023SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 RESULTS SETS 2023
Surgery Partners, Inc. has reported its financial results for the fourth quarter and full year ended December 31, 2022. The company demonstrated significant revenue growth of 15.9% in Q4 2022, reaching $707.1 million, as well as a 14.1% increase in annual revenue to $2.5 billion. Despite reporting a net loss of $23.4 million for Q4, Adjusted EBITDA showed positive growth, rising 5.6% for the fourth quarter and 12% for the full year. Looking ahead, Surgery Partners anticipates revenues exceeding $2.75 billion and Adjusted EBITDA more than $425 million in 2023.
Read more →-SGRY
Nov 8, 2022SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2022
SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2022 RESULTS BRENTWOOD, Tenn., November 8, 2022 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ SGRY) ( Surgery Partners or the Company ), a leading provider of surgical services, today announced results for the third quarter ende
Read more →-SGRY
Aug 2, 2022▼ -7.4%on this news
SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2022 RESULTS Revenue increased 13.3% from the prior year period to $615.4 million Days adjusted same-facility revenues increased 6.9% from the prior year period Net loss at
SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2022 RESULTS Revenue increased 13.3% from the prior year period to $615.4 million Days adjusted same-facility revenues increased 6.9% from the prior year period Net loss attributable to common stockholders was $18.4 million Adju
Read more →-SGRY
May 3, 2022▲ +7.2%on this news
SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2022 RESULTS Revenues increased 16.4% to $596.2 million, when compared to the prior year period Days adjusted same-facility revenues increased 8.2% from the prior year perio
SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2022 RESULTS Revenues increased 16.4% to $596.2 million, when compared to the prior year period Days adjusted same-facility revenues increased 8.2% from the prior year period Days adjusted same-facility case volume increased 6.3%
Read more →-SGRY
Feb 28, 2022SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 RESULTS RAISES 2022 GUIDANCE Net loss attributable to common stockholders was $0.1 million for the fourth quarter 2021 $81.2 million for the full-year 20
SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 RESULTS RAISES 2022 GUIDANCE Net loss attributable to common stockholders was $0.1 million for the fourth quarter 2021 $81.2 million for the full-year 2021 Fourth quarter 2021 Adjusted EBITDA increased 26.0% ove
Read more →-SGRY
Jan 10, 2022SURGERY PARTNERS REAFFIRMS 2021 AND 2022 FULL YEAR GUIDANCE DAVID T. DOHERTY TO ASSUME ROLE OF CHIEF FINANCIAL OFFICER ON FEBRUARY 1, 2022
SURGERY PARTNERS REAFFIRMS 2021 AND 2022 FULL YEAR GUIDANCE DAVID T. DOHERTY TO ASSUME ROLE OF CHIEF FINANCIAL OFFICER ON FEBRUARY 1, 2022 BRENTWOOD, Tenn., January 10, 2022 (GLOBE NEWSWIRE) -- Members of management of Surgery Partners, Inc. (NASDAQ SGRY) ( Surgery Partners or t
Read more →-SGRY
Nov 2, 2021SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2021
SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2021 RESULTS BRENTWOOD, Tenn., November 2, 2021 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ SGRY) ( Surgery Partners or the Company ), a leading provider of surgical services, today announced results for the third quarter ende
Read more →-SGRY
Aug 17, 2021▼ -6.8%on this news
Investor Presentation - August 2021 2021 Surgery Partners - Confidential & Proprietary Information Legal Disclaimer 2 Forward - Looking Statements Statements contained in this presentation, other than statements of histo
Investor Presentation - August 2021 2021 Surgery Partners - Confidential & Proprietary Information Legal Disclaimer 2 Forward - Looking Statements Statements contained in this presentation, other than statements of historical fact, are forward - looking statements . In some case
Read more →-SGRY
Aug 4, 2021▼ -15%on this news
SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2021
SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2021 RESULTS BRENTWOOD, Tenn., August 4, 2021 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ SGRY) ( Surgery Partners or the Company ), a leading provider of surgical services, today announced results for the second quarter ende
Read more →-SGRY
May 5, 2021SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2021
SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2021 RESULTS COMPLETES REFINANCING TRANSACTIONS BRENTWOOD, Tenn., May 5, 2021 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ SGRY) ( Surgery Partners or the Company ), a leading provider of surgical services, today announced resu
Read more →-SGRY
Mar 31, 2021Lender Presentation April 2021 2 Legal Disclaimer Forward - Looking Statements This presentation contains "forward - looking" statements, including statements regarding the anticipated conversion of the Series A Preferre
Lender Presentation April 2021 2 Legal Disclaimer Forward - Looking Statements This presentation contains "forward - looking" statements, including statements regarding the anticipated conversion of the Series A Preferred Stock, the Incremental Term Loan, including its anticipat
Read more →-SGRY
Mar 10, 2021SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2020
SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2020 RESULTS BRENTWOOD, Tenn., March 10, 2021 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ SGRY) ( Surgery Partners or the Company ), a leading provider of surgical services, today announced results for the fourt
Read more →-SGRY
Nov 4, 2020SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2020
SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2020 RESULTS BRENTWOOD, Tenn., November 4, 2020 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ SGRY) ( Surgery Partners or the Company ), a leading short-stay surgical facility owner and operator, today announced results for the
Read more →-SGRY
Aug 5, 2020SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2020
SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2020 RESULTS BRENTWOOD, Tenn., August 5, 2020 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ SGRY) ( Surgery Partners or the Company ), a leading short-stay surgical facility owner and operator, today announced results for the s
Read more →-SGRY
Jul 24, 2020Surgery Partners, Inc. Announces Pricing of Incremental Note Offering Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") today announced that its wholly-owned subsidiary, Surgery Center Holdings,
Surgery Partners, Inc. Announces Pricing of Incremental Note Offering Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") today announced that its wholly-owned subsidiary, Surgery Center Holdings, Inc. (the "Issuer"), priced $115.0 million aggregate prin
Read more →-SGRY
Jul 22, 2020Legal Disclaimer Forward-Looking Statements This presentation contains forward-looking statements, which are based on our current expectations, estimates and assumptions about future events. All statements other than sta
For the years ended December 31, 2019 and 2018, this amount includes a loss on litigation settlements of $0.2 million and $46.0 million, respectively. This amount further includes other litigation costs of $4.4 million for the year ended December 31, 2019, with no comparable cost
Read more →-SGRY
May 11, 2020SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2020
SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2020 RESULTS BRENTWOOD, Tenn., May 11, 2020 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the fi
Read more →-SGRY
Mar 5, 2020SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2019
SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2019 RESULTS BRENTWOOD, Tenn., March 5, 2020 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the four
Read more →-SGRY
Jan 13, 2020SURGERY PARTNERS, INC. ANNOUNCES EXECUTIVE PROMOTIONS Wayne S. DeVeydt appointed to Executive Chairman of the Board Eric Evans appointed to Chief Executive Officer Company reaffirms 2019 full year guidance of double-digi
SURGERY PARTNERS, INC. ANNOUNCES EXECUTIVE PROMOTIONS Wayne S. DeVeydt appointed to Executive Chairman of the Board Eric Evans appointed to Chief Executive Officer Company reaffirms 2019 full year guidance of double-digit Adjusted EBITDA growth BRENTWOOD, Tenn., January 13, 2
Read more →-SGRY
Nov 5, 2019SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2019
SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2019 RESULTS BRENTWOOD, Tenn., November 5, 2019 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for th
Read more →-SGRY
Aug 7, 2019SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2019
SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2019 RESULTS BRENTWOOD, Tenn., August 7, 2019 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the second quarter en
Read more →-SGRY
May 8, 2019SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2019
SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2019 RESULTS BRENTWOOD, Tenn., May 8, 2019 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the first quarter ended M
Read more →-SGRY
Mar 29, 2019Surgery Partners, Inc. (NASDAQ:SGRY) ( Surgery Partners ) today announced that its wholly-owned subsidiary, Surgery Center Holdings, Inc. (the Issuer ), priced $430,000,000 aggregate principal amount of its 10.000% senio
Surgery Partners, Inc. (NASDAQ:SGRY) ( Surgery Partners ) today announced that its wholly-owned subsidiary, Surgery Center Holdings, Inc. (the Issuer ), priced $430,000,000 aggregate principal amount of its 10.000% senior unsecured notes due 2027 (the notes ) in a previously anno
Read more →-SGRY
Mar 25, 2019Surgery Partners, Inc. (NASDAQ:SGRY) ( Surgery Partners ) today announced that its wholly-owned subsidiary, Surgery Center Holdings, Inc. (the Issuer ), intends to offer, subject to market and other considerations, $430,
Surgery Partners, Inc. (NASDAQ:SGRY) ( Surgery Partners ) today announced that its wholly-owned subsidiary, Surgery Center Holdings, Inc. (the Issuer ), intends to offer, subject to market and other considerations, $430,000,000 aggregate principal amount of senior unsecured notes
Read more →-SGRY
Mar 13, 2019SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2018 RESULTS Same Store Volume and Revenue Growth, Along with Expanding Margins, Highlight Progress of Strategic Growth Initiatives
SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2018 RESULTS Same Store Volume and Revenue Growth, Along with Expanding Margins, Highlight Progress of Strategic Growth Initiatives BRENTWOOD, Tenn., March 13, 2019 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:S
Read more →-SGRY
Feb 11, 2019Surgery Partners Announces Appointment of Eric Evans as Executive Vice President and Chief Operating Officer
Surgery Partners Announces Appointment of Eric Evans as Executive Vice President and Chief Operating Officer NASHVILLE, Tenn., February 11, 2019 -- Surgery Partners, Inc. (NASDAQ:SGRY) (the "Company"), a leading healthcare services company, today announced that Eric Evans has b
Read more →-SGRY
Nov 7, 2018SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2018 RESULTS Near Term Results Reflect Ongoing Traction of Strategic Growth Initiatives; Continued Investments to Drive Accelerated Growth in 2019
SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2018 RESULTS Near Term Results Reflect Ongoing Traction of Strategic Growth Initiatives; Continued Investments to Drive Accelerated Growth in 2019 BRENTWOOD, Tenn., November 7, 2018 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ
Read more →-SGRY
Oct 24, 2018Surgery Partners, Inc. Announces Closing of New $180 Million Incremental Term Loan
Surgery Partners, Inc. Announces Closing of New $180 Million Incremental Term Loan NASHVILLE, Tenn., October 24, 2018 Surgery Partners, Inc. (NASDAQ: SGRY) ( Surgery Partners ), a leading healthcare services company, today announced that Surgery Center Holdings, Inc., our wholly
Read more →-SGRY
Oct 11, 2018Lender Presentation October 2018 Legal Disclaimer Forward-Looking Statements Statements contained in this presentation, including the question and answer portion of the presentation, other than statements of historical f
Lender Presentation October 2018 Legal Disclaimer Forward-Looking Statements Statements contained in this presentation, including the question and answer portion of the presentation, other than statements of historical fact, are forward-looking statements. In some cases, you can
Read more →-SGRY
Aug 9, 2018SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2018 RESULTS Strategic Initiatives Begin to Yield Near-Term Results, Position the Company for Significant Growth in 2019 and Beyond
SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2018 RESULTS Strategic Initiatives Begin to Yield Near-Term Results, Position the Company for Significant Growth in 2019 and Beyond BRENTWOOD, Tenn., August 9, 2018 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery
Read more →-SGRY
May 9, 2018SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2018 RESULTS Quarterly Highlights Reflect Significant Strategic Progress; Affirms Full Year Expectations
SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2018 RESULTS Quarterly Highlights Reflect Significant Strategic Progress; Affirms Full Year Expectations BRENTWOOD, Tenn., May 9, 2018 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a
Read more →-SGRY
Mar 12, 2018Surgery Partners Announces Appointment of Thomas Cowhey as Chief Financial Officer
Surgery Partners Announces Appointment of Thomas Cowhey as Chief Financial Officer NASHVILLE, Tenn., March 12, 2018 Surgery Partners, Inc. (NASDAQ:SGRY) (the Company ), a leading healthcare services company, today announced that Thomas Cowhey has been appointed Chief Financial O
Read more →-SGRY
Mar 1, 2018SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017
SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 RESULTS NASHVILLE, Tenn., March 1, 2018 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the four
Read more →-SGRY
Jan 29, 2018Surgery Partners Announces Executive Leadership Transitions David Kretschmer appointed Chief Strategy and Transformation Officer; Executive with more than 35 years of financial and corporate strategy experience Mr. Krets
Surgery Partners Announces Executive Leadership Transitions David Kretschmer appointed Chief Strategy and Transformation Officer; Executive with more than 35 years of financial and corporate strategy experience Mr. Kretschmer to serve as interim Chief Financial Officer, follow
Read more →-SGRY
Jan 8, 2018Surgery Partners Announces Appointment of Wayne S. DeVeydt as Chief Executive Officer Committed managed care executive with more than 20 years of operational, strategic and financial experience, well-positioned to spearh
Surgery Partners Announces Appointment of Wayne S. DeVeydt as Chief Executive Officer Committed managed care executive with more than 20 years of operational, strategic and financial experience, well-positioned to spearhead Surgery Partners next phase of growth NASHVILLE, Tenn
Read more →-SGRY
Dec 15, 2017SURGERY PARTNERS, INC. ANNOUNCES $50.0
SURGERY PARTNERS, INC. ANNOUNCES $50.0 MILLION SHARE REPURCHASE PROGRAM BRENTWOOD, Tenn., December 15, 2017 - Surgery Partners, Inc. (NASDAQ:SGRY) ( Surgery Partners or the Company ), a leading provider of surgical services, today announced that its Board of Directors has author
Read more →-SGRY
Nov 8, 2017SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2017 RESULTS Integration with National Surgical Healthcare Progressing as Planned; Near-Term Initiatives Set to Drive Growth
SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2017 RESULTS Integration with National Surgical Healthcare Progressing as Planned; Near-Term Initiatives Set to Drive Growth NASHVILLE, Tenn., November 8, 2017 - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Comp
Read more →-SGRY
Oct 31, 2017Surgery Partners Provides Update on 2017 Third Quarter Results
Surgery Partners Provides Update on 2017 Third Quarter Results NASHVILLE, Tenn., October 31, 2017 -- Surgery Partners, Inc. (NASDAQ:SGRY) (the "Company"), a leading healthcare services company, today announced preliminary financial results for its third quarter ended September 3
Read more →-SGRY
Sep 7, 2017Surgery Partners Announces Appointment of Clifford Adlerz as Interim Chief Executive Officer Veteran healthcare services leader to drive operational excellence and accelerate growth initiatives Search for permanent CEO u
Surgery Partners Announces Appointment of Clifford Adlerz as Interim Chief Executive Officer Veteran healthcare services leader to drive operational excellence and accelerate growth initiatives Search for permanent CEO underway NASHVILLE, Tenn., Sept. 7, 2017 Surgery Partners
Read more →-SGRY
Aug 31, 2017Surgery Partners Completes Acquisition of National Surgical Healthcare Combination creates leading independent surgery company with strong musculoskeletal programs Bain Capital Private Equity completes acquisition of H.I
Surgery Partners Completes Acquisition of National Surgical Healthcare Combination creates leading independent surgery company with strong musculoskeletal programs Bain Capital Private Equity completes acquisition of H.I.G. Capital s stake in Surgery Partners with the NSH close
Read more →-SGRY
Aug 8, 2017SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2017 RESULTS Transaction with National Surgical Healthcare Progressing as Planned with Third Quarter Close Date
SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2017 RESULTS Transaction with National Surgical Healthcare Progressing as Planned with Third Quarter Close Date NASHVILLE, Tenn., August 8, 2017 - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leadi
Read more →-SGRY
Jun 19, 2017SUMMARY UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION The following summary pro forma financial data has been derived from our historical financial statements and the historical financial statements of Nat
SUMMARY UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION The following summary pro forma financial data has been derived from our historical financial statements and the historical financial statements of National Surgical Healthcare included elsewhere in this offeri
Read more →-SGRY
Jun 5, 2017Surgery Partners, Inc. Announces New Appointments to the Board of Directors
Surgery Partners, Inc. Announces New Appointments to the Board of Directors NASHVILLE, Tennessee, June 5, 2017 - Surgery Partners, Inc. (NASDAQ: SGRY) (the "Company"), today announced the appointment of Christopher R. Gordon and conditional appointment of T. Devin O'Reilly to it
Read more →-SGRY
May 25, 2017Surgery Partners, Inc. Announces Receipt of Requisite Consents and Expiration of its Consent Solicitation Relating to its Senior Notes
Surgery Partners, Inc. Announces Receipt of Requisite Consents and Expiration of its Consent Solicitation Relating to its Senior Notes NEW YORK - May 25, 2017 - Surgery Partners, Inc. ("Surgery Partners") announced today that Surgery Center Holdings, Inc., a Delaware corporation
Read more →-SGRY
May 18, 2017CONSENT SOLICITATION STATEMENT SURGERY CENTER HOLDINGS, INC. Solicitation of Consents Relating to the Proposed Amendments of the Indenture Relating to the 8.875% Senior Notes due 2021 (CUSIP Nos. 86881WAA0, 86881WAB8 (AI
CONSENT SOLICITATION STATEMENT SURGERY CENTER HOLDINGS, INC. Solicitation of Consents Relating to the Proposed Amendments of the Indenture Relating to 8.875% Senior Notes due 2021 (CUSIP Nos. 86881WAA0, 86881WAB8 (AI) and U86786AA5 and ISIN Nos. US86881WAA09, US86881WAB81 and
Read more →-SGRY
May 10, 2017Surgery Partners to Acquire National Surgical Healthcare from Irving Place Capital Combination creates leading independent surgery company with strong musculoskeletal programs Transaction expected to be accretive in 2018
Surgery Partners to Acquire National Surgical Healthcare from Irving Place Capital Combination creates leading independent surgery company with strong musculoskeletal programs Transaction expected to be accretive in 2018 Bain Capital Private Equity acquiring H.I.G. Capital s s
Read more →-SGRY
May 9, 2017SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2017 RESULTS Revenues increase 7.2% over prior year period driven by strong same-facility revenue growth of 7.8%
SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2017 RESULTS Revenues increase 7.2% over prior year period driven by strong same-facility revenue growth of 7.8% NASHVILLE, Tenn., May 9, 2017 - Surgery Partners, Inc. (NASDAQ:SGRY) ( Surgery Partners or the Company ), a leading p
Read more →-SGRY
May 9, 2017Bridge Presentation May 2017 Legal Disclaimer This document has been prepared solely for use of the recipient. You agree to hold the Information contained herein in strict confidence and may not reproduce, distribute or
Legal Disclaimer This document has been prepared solely for use of the recipient. You agree to hold the Information contained herein in strict confidence and may not reproduce, distribute or disclose this Information, in whole or in part. Forward-Looking Statements This presenta
Read more →-SGRY
Mar 9, 2017SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2016 RESULTS Fourth quarter revenues increase 16% over prior year period driven by strong same facility revenue growth.
SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2016 RESULTS Fourth quarter revenues increase 16% over prior year period driven by strong same facility revenue growth. NASHVILLE, Tennessee, March 9, 2017 - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" o
Read more →-SGRY
Nov 9, 2016SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2016 RESULTS Revenues increase 18% over prior year period driven by strong same-facility revenue growth of 10%
SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2016 RESULTS Revenues increase 18% over prior year period driven by strong same-facility revenue growth of 10% NASHVILLE, Tenn., November 9, 2016 - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leadi
Read more →-SGRY
Sep 30, 2016Surgery Partners, Inc. Appoints Teresa DeLuca, M.D. to the Board of Directors
Surgery Partners, Inc. Appoints Teresa DeLuca, M.D. to the Board of Directors NASHVILLE, Tennessee, September 30, 2016 - Surgery Partners, Inc. (NASDAQ: SGRY) (the "Company"), today announced the appointment of Teresa DeLuca, M.D. to its Board of Directors effective September 30
Read more →-SGRY
Aug 10, 2016CORRECTED SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2016 RESULTS Revenues increase 24% over prior year period driven by strong same-facility revenue growth of 15%
CORRECTED SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2016 RESULTS Revenues increase 24% over prior year period driven by strong same-facility revenue growth of 15% NASHVILLE, Tenn., August 10, 2016 - The press release issued by Surgery Partners, Inc. (NASDAQ:SGRY) on Augus
Read more →-SGRY
Aug 9, 2016SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2016 RESULTS Revenues increase 24% over prior year period driven by strong same-facility revenue growth of 15%
SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2016 RESULTS Revenues increase 24% over prior year period driven by strong same-facility revenue growth of 15% NASHVILLE, Tenn., August 9, 2016 - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leadin
Read more →-SGRY
May 5, 2016SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2016 RESULTS Revenues increase 19% over prior year period driven by strong same-facility revenue growth of 13.3%
SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2016 RESULTS Revenues increase 19% over prior year period driven by strong same-facility revenue growth of 13.3% NASHVILLE, Tenn., May 5, 2016 - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading
Read more →-SGRY
Mar 29, 2016Surgery Partners Announces Pricing of $400 Million Senior Note Offering
Surgery Partners Announces Pricing of $400 Million Senior Note Offering NASHVILLE, Tennessee, March 29, 2016 Surgery Partners, Inc. (NASDAQ: SGRY) today announced that its wholly owned subsidiary, Surgery Center Holdings, Inc. (collectively, Surgery Partners ), priced $400,000,
Read more →-SGRY
Mar 18, 2016Surgery Partners Announces Proposed $400 Million Senior Note Offering
Surgery Partners Announces Proposed $400 Million Senior Note Offering NASHVILLE, Tennessee, March 18, 2016 Surgery Partners, Inc. (NASDAQ: SGRY) today announced that its wholly-owned subsidiary, Surgery Center Holdings, Inc. (collectively, Surgery Partners ), intends to commenc
Read more →-SGRY
Mar 15, 2016Name: Number of Shares of Restricted Stock: Date of Grant: S URGERY P ARTNERS , I NC . 2015 O MNIBUS I NCENTIVE P LAN F ORM O F R ESTRICTED S TOCK A WARD A GREEMENT This agreement (the Agreement ) evidences a grant of Re
Name: Number of Shares of Restricted Stock: Date of Grant: SURGERY PARTNERS, INC. 2015 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK AWARD AGREEMENT This agreement (the Agreement ) evidences a grant of Restricted Stock by Surgery Partners, Inc. (the Company ) to the undersig
Read more →-SGRY
Mar 14, 2016Executive Summary Surgery Partners, Inc. ("Surgery Partners" or the "Company") is a leading surgical services company with a differentiated outpatient care delivery model National platform of 101 surgical facilities comp
Lender Presentation March 2016 Exhibit 2 Executive Summary Surgery Partners, Inc. ("Surgery Partners" or the "Company") is a leading surgical services company with a differentiated outpatient care delivery model National platform of 101 surgical facilities comprised of 96 ambul
Read more →-SGRY
Mar 10, 2016SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2015 RESULTS Fourth quarter revenues increase 47% over prior year period driven by strong same facility revenue growth.
SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2015 RESULTS Fourth quarter revenues increase 47% over prior year period driven by strong same facility revenue growth. NASHVILLE, Tennessee, March 10, 2016 - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners"
Read more →-SGRY
Dec 30, 2015Surgery Partners, Inc. Appoints Brent Turner to the Board of Directors
Surgery Partners, Inc. Appoints Brent Turner to the Board of Directors NASHVILLE, Tennessee, December 30, 2015 - Surgery Partners, Inc. (NASDAQ: SGRY) ("the Company"), today announced the appointment of Brent Turner to its Board of Directors effective December 30, 2015. In addit
Read more →-SGRY
Nov 12, 2015SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2015 RESULTS Revenues increase 214% over prior year period
SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2015 RESULTS Revenues increase 214% over prior year period NASHVILLE, Tenn., November 12, 2015 - Surgery Partners, Inc. (NASDAQ:SGRY) (or the "Company"), a leading provider of surgical services, today announced results for the thir
Read more →Competitive Position
How SGRY ranks across every disease it competes inCompetitive Position is a premium feature
See how SGRY ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial